Learn more about whether Blueprint Medicines Corporation or Zai Lab Limited is a better investment based on AAII's A+ ...

Zenas BioPharma Inc (Zenas), a clinical-stage global biopharmaceutical company, has outlined its significant achievements in 2024 and set key business objectives for 2025. The company also announced ...

After hours: February 3 at 4:45:21 PM EST Loading Chart for ZLAB ...

Dynatrace , the leading AI-powered observability platform, today announced Observability for Developers, a comprehensive set of solutions that empower the developer community with runtime insights and ...

Dynatrace , the leading AI-powered observability platform, today announced a significant expansion of its powerful AI engine, Davis® AI, that can move enterprises beyond reactive AIOps to true ...

The "Pharmaceutical Review Designations: Trends and Industry Insights" report has been added to ResearchAndMarkets.com's offering.This report investigates review designations in the pharmaceutical ...

Dublin, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The "Antibiotic Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Antibiotic Collaboration and ...

Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced non ...